Zumilokibart (APG777) trials continue to advance in atopic dermatitis (AD) with plans for expansion indications underway:- APEX Phase 2 Part A ...
Jacob Johnson joins Apogee Architectural Metals as vice president of sales for the western and southern regions. Johnson reports directly to company president Troy Johnson (no relation), and works ...
This biotech specializes in monoclonal antibody therapies for inflammatory and immunological diseases with significant unmet ...
Health Care in Focus” is a new white paper from Apogee Architectural Metals addressing facility-focused design aspirations ...
Apogee Therapeutics recently presented at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 at the Lotte New York Palace Hotel in New York, highlighting its pipeline to an audience of ...
StockStory.org on MSN
3 reasons to sell APOG and 1 stock to buy instead
Since August 2025, Apogee has been in a holding pattern, posting a small loss of 4% while floating around $40.96. The stock ...
One takeaway from the ongoing biotech IPO drought is that companies should have at least some clinical data to persuade investors to buy in. Apogee Therapeutics has no human data. In fact, the young ...
The new Apogee Boom audio interface if designed for musicians and live streamers who want pro-quality audio at an entry level price. Apogee Electronics has been making digital audio recording ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results